05.21.15
Molex Inc., a manufacturer of electronic interconnect solutions, has acquired ProTek Medical Ltd. through its Molex Ireland Holdings B.V. division.
Founded in 1995 and headquartered in Sligo, Ireland, ProTek Medical has a diverse portfolio, with applications that include cardiac rhythm management components, infusion finished devices, and vascular delivery devices. Among its service offerings are design, engineering, manufacturing, finished assembly and testing of critical medical devices.
"This strategic acquisition broadens the scope of our integrated medical solution offerings and significantly strengthens our medical device design, manufacturing, and test capabilities," said Tim Ruff, senior vice president of business development and corporate strategy, Molex. "ProTek Medical Ltd. excels in clean-room injection molding and assembly, has an extensive metrology lab, and the quality and regulatory expertise that is critical to global medical device manufacturers."
ProTek Medical Ltd. will continue to operate as a subsidiary of Molex Ireland Holdings, B.V. The acquisition also expands the Molex medical footprint to Ireland, which has a large concentration of successful medical device companies.
"The acquisition presents new opportunities to achieve faster growth by expanding into new regions and healthcare market segments," said Frank Boyle, founder and CEO, ProTek Medical Ltd. "Our customers will benefit from the unique capabilities, electromechanical technologies and global supply chain that Molex offers. We will now have the ability to easily scale to serve high-mix, low- and high-volume production requirements to SME (small and medium enterprises) and large medical device OEM customers worldwide."
Molex, based in Lisle, Ill., makes interconnect solutions for a number of markets including: data communications, telecommunications, consumer electronics, industrial, automotive, commercial vehicle, aerospace and defense, medical, and lighting. Established 1938, the company operates 50 manufacturing locations in 17 countries, and is an indirect subsidiary of Koch Industries Inc.
Founded in 1995 and headquartered in Sligo, Ireland, ProTek Medical has a diverse portfolio, with applications that include cardiac rhythm management components, infusion finished devices, and vascular delivery devices. Among its service offerings are design, engineering, manufacturing, finished assembly and testing of critical medical devices.
"This strategic acquisition broadens the scope of our integrated medical solution offerings and significantly strengthens our medical device design, manufacturing, and test capabilities," said Tim Ruff, senior vice president of business development and corporate strategy, Molex. "ProTek Medical Ltd. excels in clean-room injection molding and assembly, has an extensive metrology lab, and the quality and regulatory expertise that is critical to global medical device manufacturers."
ProTek Medical Ltd. will continue to operate as a subsidiary of Molex Ireland Holdings, B.V. The acquisition also expands the Molex medical footprint to Ireland, which has a large concentration of successful medical device companies.
"The acquisition presents new opportunities to achieve faster growth by expanding into new regions and healthcare market segments," said Frank Boyle, founder and CEO, ProTek Medical Ltd. "Our customers will benefit from the unique capabilities, electromechanical technologies and global supply chain that Molex offers. We will now have the ability to easily scale to serve high-mix, low- and high-volume production requirements to SME (small and medium enterprises) and large medical device OEM customers worldwide."
Molex, based in Lisle, Ill., makes interconnect solutions for a number of markets including: data communications, telecommunications, consumer electronics, industrial, automotive, commercial vehicle, aerospace and defense, medical, and lighting. Established 1938, the company operates 50 manufacturing locations in 17 countries, and is an indirect subsidiary of Koch Industries Inc.